Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,325
New position
Shares Held
93
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#283
of 331 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 100%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quarry LP holds $3,286,514 across 21 Drug Manufacturers - Specialty & Generic names. SUPN ranks #4 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
25,800 | $2,057,034 | |
| 2 | XERS |
Xeris Biopharma Holdings, Inc.
|
150,057 | $1,188,451 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
151 | $5,235 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
93 | $4,325 | |
| 5 | BCRX |
Biocryst Pharmaceuticals Inc
|
404 | $4,040 | |
| 6 | ZTS |
Zoetis Inc.
|
55 | $3,952 | |
| 7 | PAHC |
Phibro Animal Health Corp
|
113 | $3,548 | |
| 8 | PCRX |
Pacira BioSciences, Inc.
|
101 | $2,562 |
All Filings in SUPN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,325 | 93 | Shares | Other | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||